Pharmaceutical Preparations companies: boards of directors (SIC 2834)
- Organizations
- 475
- Directors
- 3,605
- Average board size
- 9.4
| Organization | Directors | CEO |
|---|---|---|
| Summit Therapeutics Inc. Nasdaq: SMMT · Miami, United States | 10 | Mahkam Zanganeh |
| Tempest Therapeutics Inc. Nasdaq: TPST · Brisbane, United States | 10 | Matthew Angel |
| Travere Therapeutics Inc. Nasdaq: TVTX · SAN Diego, United States | 10 | Eric M. Dube |
| Verrica Pharmaceuticals Inc. Nasdaq: VRCA · West Chester, United States | 10 | Jayson Rieger |
| Viridian Therapeutics Inc. Nasdaq: VRDN · Waltham, United States | 10 | Stephen F. Mahoney |
| Wave Life Sciences Inc. Nasdaq: WVE · Cambridge, Singapore | 10 | Paul Bolno |
| Xencor Inc. Nasdaq: XNCR · Pasadena, United States | 10 | Bassil I. Dahiyat |
| Xenon Pharmaceuticals Inc. Nasdaq: XENE · Burnaby, Canada | 10 | Ian Mortimer |
| Zai Lab Limited Nasdaq: ZLAB · Shanghai, China | 10 | Ying Du |
| Zentalis Pharmaceuticals Inc. Nasdaq: ZNTL · SAN Diego, United States | 10 | Julia Marie Eastland |
| Actuate Therapeutics Inc. Nasdaq: ACTU · Fort Worth, United States | 9 | Daniel M. Schmitt |
| Akebia Therapeutics Inc. Nasdaq: AKBA · Cambridge, United States | 9 | John P. Butler |
| Aktis Oncology Inc. Nasdaq: AKTS · Boston, United States | 9 | Matthew Roden |
| Alaunos Therapeutics Inc. Nasdaq: TCRT · Fort Lauderdale, United States | 9 | Dale Curtis Hogue Jr. |
| Aldeyra Therapeutics Inc. Nasdaq: ALDX · Lexington, United States | 9 | Todd C. Brady |
| Alto Neuroscience Inc. NYSE: ANRO · Mountain View, United States | 9 | Amit Etkin |
| Alumis Inc. Nasdaq: ALMS · South SAN Francisco, United States | 9 | Martin Babler |
| AN2 Therapeutics Inc. Nasdaq: ANTX · Menlo Park, United States | 9 | Eric Easom |
| Annexon Inc. Nasdaq: ANNX · Brisbane, United States | 9 | Douglas Love |
| Apollomics Inc. Nasdaq: APLM · Covina, United States | 9 | Hung-Wen Chen |
| Aprea Therapeutics Inc. Nasdaq: APRE · Doylestown, United States | 9 | Oren Gilad |
| Aquestive Therapeutics Inc. Nasdaq: AQST · Warren, United States | 9 | Daniel Barber |
| Arcturus Therapeutics Holdings Inc. Nasdaq: ARCT · SAN Diego, Israel | 9 | Joseph E. Payne |
| ArriVent BioPharma Inc. Nasdaq: AVBP · Newtown Square, United States | 9 | Zhengbin Yao |
| Ascentage Pharma Group International Nasdaq: AAPG · Suzhou , Jiangsu, China | 9 | Dajun Yang |
| Atea Pharmaceuticals Inc. Nasdaq: AVIR · Boston, United States | 9 | Jean-Pierre Sommadossi |
| Benitec Biopharma Inc. Nasdaq: BNTC · Hayward, United States | 9 | Jerel A. Banks |
| Biohaven Ltd. NYSE: BHVN · New Haven, United States | 9 | Vlad Coric |
| Braveheart Bio Inc. Nasdaq: BRVE · SAN Francisco, United States | 9 | Travis Murdoch |
| CDT Equity Inc. Nasdaq: CDT · Naples, United States | 9 | David Tapolczay |
| Citius Oncology Inc. Nasdaq: CTOR · Cranford, United States | 9 | Leonard L. Mazur |
| Corcept Therapeutics Incorporated Nasdaq: CORT · Redwood City, United States | 9 | Joseph K. Belanoff |
| Coya Therapeutics Inc. Nasdaq: COYA · Houston, United States | 9 | Howard Berman |
| CytomX Therapeutics Inc. Nasdaq: CTMX · South SAN Francisco, United States | 9 | Sean A. McCarthy |
| DiaMedica Therapeutics Inc. Nasdaq: DMAC · Minneapolis, United States | 9 | Dietrich John Pauls |
| Dogwood Therapeutics Inc. Nasdaq: DWTX · Alpharetta, United States | 9 | Gregory Scott Duncan |
| Dr. Reddy's Laboratories Ltd NYSE: RDY · Hyderabad, India | 9 | — |
| Edgewise Therapeutics Inc. Nasdaq: EWTX · Boulder, United States | 9 | Kevin Koch |
| Elicio Therapeutics Inc. Nasdaq: ELTX · Boston, United States | 9 | Robert Connelly |
| Erasca Inc. Nasdaq: ERAS · SAN Diego, United States | 9 | Jonathan E. Lim |
| Evolus Inc. Nasdaq: EOLS · Newport Beach, United States | 9 | — |
| Fortress Biotech Inc. Nasdaq: FBIO · Bay Harbor Islands, United States | 9 | Lindsay A. Rosenwald M.D. |
| Gain Therapeutics Inc. Nasdaq: GANX · Bethesda, United States | 9 | Matthias Alder |
| Generate Biomedicines Inc. Nasdaq: GENB · Somerville, United States | 9 | Michael Nally |
| Hyperion DeFi Inc. Nasdaq: HYPD · Dallas, United States | 9 | Michael M. Rowe |
| IDEAYA Biosciences Inc. Nasdaq: IDYA · South SAN Francisco, United States | 9 | Yujiro S. Hata |
| Immix Biopharma Inc. Nasdaq: IMMX · LOS Angeles, United States | 9 | Ilya M. Rachman |
| Innoviva Inc. Nasdaq: INVA · Burlingame, United States | 9 | Pavel Raifeld |
| Ironwood Pharmaceuticals Inc. Nasdaq: IRWD · Boston, United States | 9 | Thomas A. Mccourt |
| Jupiter Neurosciences Inc. Nasdaq: JUNS · Jupiter, United States | 9 | Christer Rosen |
Organizations whose headquarters, sector or industry code is on file and that have at least one current director. Sectors not on file are derived from the industry code (an approximate match to GICS). Board sizes count every current seat on record; see where our data comes from.